Cargando…

Considerations for Subgroups and Phenocopies in Complex Disease Genetics

The number of identified genetic variants associated to complex disease cannot fully explain heritability. This may be partially due to more complicated patterns of predisposition than previously suspected. Diseases such as multiple sclerosis (MS) may consist of multiple disease causing mechanisms,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanujam, Ryan, Ramanujam, S., Hillert, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748062/
https://www.ncbi.nlm.nih.gov/pubmed/23977088
http://dx.doi.org/10.1371/journal.pone.0071614
_version_ 1782281027010428928
author Ramanujam, Ryan
Ramanujam, S.
Hillert, Jan
author_facet Ramanujam, Ryan
Ramanujam, S.
Hillert, Jan
author_sort Ramanujam, Ryan
collection PubMed
description The number of identified genetic variants associated to complex disease cannot fully explain heritability. This may be partially due to more complicated patterns of predisposition than previously suspected. Diseases such as multiple sclerosis (MS) may consist of multiple disease causing mechanisms, each comprised of several elements. We describe how the effect of subgroups can be calculated using the standard association measurement odds ratio, which is then manipulated to provide a formula for the true underlying association present within the subgroup. This is sensitive to the initial minor allele frequencies present in both cases and the subgroup of patients. The methodology is then extended to the χ(2) statistic, for two related scenarios. First, to determine the true χ(2) when phenocopies or disease subtypes reduce association and are reclassified as controls when calculating statistics. Here, the χ(2) is given by[Image: see text], or [Image: see text] for equal numbers of cases and controls. Second, when subgroups corresponding to heterogeneity mask the true effect size, but no reclassification is made. Here, the proportion increase in total sample size required to attain the same χ(2) statistic as the subgroup is given as [Image: see text], and a python script to calculate and plot this value is provided at kirc.se. Practical examples show how in a study of modest size (1000 cases and 1000 controls), a non-significant SNP may exceed genome-wide significance when corresponding to a subgroup of 20% of cases, and may occur in heterozygous form in all cases. This methodology may explain the modest association found in diseases such as MS wherein heterogeneity confounds straightforward measurement of association.
format Online
Article
Text
id pubmed-3748062
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37480622013-08-23 Considerations for Subgroups and Phenocopies in Complex Disease Genetics Ramanujam, Ryan Ramanujam, S. Hillert, Jan PLoS One Research Article The number of identified genetic variants associated to complex disease cannot fully explain heritability. This may be partially due to more complicated patterns of predisposition than previously suspected. Diseases such as multiple sclerosis (MS) may consist of multiple disease causing mechanisms, each comprised of several elements. We describe how the effect of subgroups can be calculated using the standard association measurement odds ratio, which is then manipulated to provide a formula for the true underlying association present within the subgroup. This is sensitive to the initial minor allele frequencies present in both cases and the subgroup of patients. The methodology is then extended to the χ(2) statistic, for two related scenarios. First, to determine the true χ(2) when phenocopies or disease subtypes reduce association and are reclassified as controls when calculating statistics. Here, the χ(2) is given by[Image: see text], or [Image: see text] for equal numbers of cases and controls. Second, when subgroups corresponding to heterogeneity mask the true effect size, but no reclassification is made. Here, the proportion increase in total sample size required to attain the same χ(2) statistic as the subgroup is given as [Image: see text], and a python script to calculate and plot this value is provided at kirc.se. Practical examples show how in a study of modest size (1000 cases and 1000 controls), a non-significant SNP may exceed genome-wide significance when corresponding to a subgroup of 20% of cases, and may occur in heterozygous form in all cases. This methodology may explain the modest association found in diseases such as MS wherein heterogeneity confounds straightforward measurement of association. Public Library of Science 2013-08-20 /pmc/articles/PMC3748062/ /pubmed/23977088 http://dx.doi.org/10.1371/journal.pone.0071614 Text en © 2013 Ramanujam et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ramanujam, Ryan
Ramanujam, S.
Hillert, Jan
Considerations for Subgroups and Phenocopies in Complex Disease Genetics
title Considerations for Subgroups and Phenocopies in Complex Disease Genetics
title_full Considerations for Subgroups and Phenocopies in Complex Disease Genetics
title_fullStr Considerations for Subgroups and Phenocopies in Complex Disease Genetics
title_full_unstemmed Considerations for Subgroups and Phenocopies in Complex Disease Genetics
title_short Considerations for Subgroups and Phenocopies in Complex Disease Genetics
title_sort considerations for subgroups and phenocopies in complex disease genetics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748062/
https://www.ncbi.nlm.nih.gov/pubmed/23977088
http://dx.doi.org/10.1371/journal.pone.0071614
work_keys_str_mv AT ramanujamryan considerationsforsubgroupsandphenocopiesincomplexdiseasegenetics
AT ramanujams considerationsforsubgroupsandphenocopiesincomplexdiseasegenetics
AT hillertjan considerationsforsubgroupsandphenocopiesincomplexdiseasegenetics